ESE-1 is a potent repressor of type II collagen gene (COL2A1) transcription in human chondrocytes

Journal of Cellular Physiology

Volumn 215, Issue 2, 2008, Pages 562-573

  Peng, Haibing ^a   Tan, Lujian ^a   Osaki, Makoto ^a   Zhan, Yumei ^a   Ijiri, Kosei ^a   Tsuchimochi, Kaneyuki ^a,b   Otero, Miguel ^a,b   Wang, Hong ^a   Choy, Bob K ^a   Grall, Franck T ^a   Gu, Xuesong ^a   Libermann, Towia A ^a   Oettgen, Peter ^a   Goldring, Mary B ^a,b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; EARLY GROWTH RESPONSE FACTOR 1; EPITHELIUM SPECIFIC TRANSCRIPTION FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; COL2A1 PROTEIN, HUMAN; DNA BINDING PROTEIN; EHF PROTEIN, HUMAN; ELF3 PROTEIN, HUMAN; ETS1 PROTEIN, HUMAN; MESSENGER RNA; ONCOPROTEIN; TRANSCRIPTION FACTOR ETS 1;

ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CHROMATIN IMMUNOPRECIPITATION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; REPRESSOR GENE; STAINING; TANDEM MASS SPECTROMETRY; TRANSCRIPTION TERMINATION; CARTILAGE; CELL CULTURE; CHROMATIN; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; TISSUE DISTRIBUTION; UPREGULATION;

CARTILAGE; CELLS, CULTURED; CHONDROCYTES; CHROMATIN; COLLAGEN TYPE II; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INTERLEUKIN-1BETA; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; RNA, SMALL INTERFERING; TISSUE DISTRIBUTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; UP-REGULATION;

EID: 40949147703     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21338     Document Type: Article

References (60)

1. Andriamanalijaona R, Felisaz N, Kim SJ, King-Jones K, Lehmann M, Pujol JP, Boumediene K. 2003. Mediation of interleukin-1b-induced transforming growth factor b1 expression by activator protein 4 transcription factor in primary cultures of bovine articular chondrocytes: Possible cooperation with activator protein 1. Arthritis Rheum 48:1569-1581.
2. Bau B, Gebhard PM, Haag J, Knorr T, Bartnik E, Aigner T. 2002. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 46:2648-2657.
3. Brown C, Gaspar J, Pettit A, Lee R, Gu X, Wang H, Manning C, Voland C, Goldring SR, Goldring MB, Libermann TA, Gravalllese EM, Oettgen P. 2004. ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammation. J Biol Chem 279:12794-12803.
4. Chadjichristos C, Ghayor C, Kypriotou M, Martin G, Renard E, Ala-Kokko L, Suske G, de Crombrugghe B, Pujol JP, Galera P. 2003. Sp1 and Sp3 transcription factors mediate interleukin-1 b down-regulation of human type II collagen gene expression in articular chondrocytes. J Biol Chem 278:39762-39772.
5. Czuwara-Ladykowska J, Shirasaki F, Jackers P, Watson DK, Trojanowska M. 2001. Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway. J Biol Chem 276:20839-20848.
6. Edwards DR, Mahadevan LC. 1992. Protein synthesis inhibitors differentially superinduce c-fos and c-jun by three distinct mechanisms: Lack of evidence for labile repressors. EMBO J 11:2415-2424.
7. Farr A, Roman A. 1992. A pitfall of using a second plasmid to determine transfection efficiency. Nucleic Acids Res 20:920.
8. Feng JQ, Xing L, Zhang JH, Zhao M, Horn D, Chan J, Boyce BF, Harris SE, Mundy GR, Chen D. 2003. NF-κB specifically activates BMP-2 gene expression in growth plate chondrocytes in vivo and in a chondrocyte cell line in vitro. J Biol Chem 278:29130-29135.
9. Foxwell B, Browne K, Bondeson J, Clarke C, de Martin R, Brennan F, Feldmann M. 1998. Efficient adenoviral infection with IkB a reveals that macrophage tumor necrosis factor a production in rheumatoid arthritis is NF-κB dependent. Proc Natl Acad Sci USA 95:8211-8215.
10. Fukui N, Zhu Y, Maloney WJ, Clohisy J, Sandell LJ. 2003. Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-α in normal and osteoarthritic chondrocytes. J Bone Joint Surg Am 85-A:59-66.
11. Goldring MB. 2004. Human chondrocyte cultures as models of cartilage-specific gene regulation. Methods Mol Med 107:69-96.
12. Goldring MB, Birkhead J, Sandell LJ, Kimura T, Krane SM. 1988. Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J Clin Invest 82:2026-2037.
13. Goldring MB, Birkhead JR, Suen L-F, Yamin R, Mizuno S, Glowacki J, Arbiser JL, Apperley JF. 1994a. Interleukin-1b-modulated gene expression in immortalized human chondrocytes. J Clin Invest 94:2307-2316.
14. Goldring MB, Fukuo K, Birkhead JR, Dudek E, Sandell LJ. 1994b. Transcriptional suppression by interleukin-1 and interferon-g of type II collagen gene expression in human chondrocytes. J Cell Biochem 54:85-99.
15. Grall F, Gu X, Tan L, Cho J-Y, Inan MS, Pettit A, Thamrongsak U, Choy BK, Manning C, Akbarali Y, Zerbini L, Rudders S, Goldring SR, Gravallese EM, Oettgen P, Goldring MB, Libermann TA. 2003. Responses to the pro-inflammatory cytokines interleukin-1 and tumor necrosis factor a in cells derived from rheumatoid synovium and other joint tissues involve NF kB-mediated induction of the Ets transcription factor ESE-1. Arthritis Rheum 48:1249-1260.
16. Grall FT, Prall WC, Wei W, Gu X, Cho JY, Choy BK, Zerbini LF, Inan MS, Goldring SR, Gravallese EM, Goldring MB, Oettgen P, Libermann TA. 2005. The Ets transcription factor ESE-1 mediates induction of the COX-2 gene by LPS in monocytes. FEBS J 272:1676-1687.
17. Gravallese EM, Pettit AR, Lee R, Madore R, Manning C, Tsay A, Gaspar J, Goldring MB, Goldring SR, Oettgen P. 2003. Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor a. Ann Rheum Dis 62:100-107.
18. Hermansson M, Sawaji Y, Bolton M, Alexander S, Wallace A, Begum S, Wait R, Saklatvala J. 2004. Proteomic analysis of articular cartilage shows increased type II collagen synthesis in osteoarthritis and expression of inhibin bA (activin A), a regulatory molecule for chondrocytes. J Biol Chem 279:43514-43521.
19. Hwang SG, Yu SS, Poo H, Chun JS. 2005. c-Jun/activator protein-1 mediates interleukin-1b-induced dedifferentiation but not cyclooxygenase-2 expression in articular chondrocytes. J Biol Chem 280:29780-29787.
20. Ijiri K, Zerbini LF, Peng H, Correa RG, Lu B, Walsh N, Zhao Y, Taniguchi N, Huang XL, Otu H, Wang H, Wang JF, Komiya S, Ducy P, Rahman MU, Flavell RA, Gravallese EM, Oettgen P, Libermann TA, Goldring MB. 2005. A novel role for GADD45b as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation. J Biol Chem 280:38544-38555.
21. Imamura T, Imamura C, Iwamoto Y, Sandell LJ. 2005. Transcriptional co-activators CREB-binding Protein/p300 increase chondrocyte Cd-rap gene expression by multiple mechanisms including sequestration of the repressor CCAAT/enhancer-binding protein. J Biol Chem 280:16625-16634.
22. Ito H, Duxbury M, Benoit E, Clancy TE, Zinner MJ, Ashley SW, Whang EE. 2004. Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2. Cancer Res 64:7439-7446.
23. Iwamoto M, Higuchi Y, Koyama E, Enomoto-Iwamoto M, Kurisu K, Yeh H, Abrams WR, Rosenbloom J, Pacifici M. 2000. Transcription factor ERG variants and functional diversification of chondrocytes during limb long bone development. J Cell Biol 150:27-40.
24. Iwamoto M, Tamamura Y, Koyama E, Komori T, Takeshita N, Williams JA, Nakamura T, Enomoto-Iwamoto M, Pacifici M. 2007. Transcription factor ERG and joint and articular cartilage formation during mouse limb and spine skeletogenesis. Dev Biol 305:40-51.
25. Jinnin M, Ihn H, Yamane K, Mimura Y, Asano Y, Tamaki K. 2005. a2(1) collagen gene regulation by protein kinase C signaling in human dermal fibroblasts. Nucleic Acids Res 33:1337-1351.
26. Kas K, Finger E, Grall F, Gu X, Akbarali Y, Boltax J, Weiss A, Oettgen P, Kapeller R, Libermann TA. 2000. ESE-3, a novel member of an epithelium-specific ets transcription factor subfamily, demonstrates different target gene specificity from ESE-1. J Biol Chem 275:2986-2998.
27. Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, Feige U, Poole AR. 2005. Role of interleukin-1 and tumor necrosis factor a in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 52:128-135.
28. Kopp JL, Wilder PJ, Desler M, Kim JH, Hou J, Nowling T, Rizzino A. 2004. Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3,and PU.1, on the promoter of the type II transforming growth factor-b receptor gene. J Biol Chem 279:19407-19420.
29. Kopp JL, Wilder PJ, Desler M, Kinarsky L, Rizzino A. 2007. Different domains of the transcription factor ELF3 are required in a promoter-specific mannerand multiple domains control its binding to DNA. J Biol Chem 282:3027-3041.
30. Lefebvre V, Li P, de Crombrugghe B. 1998. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 17:5718-5733.
31. Legendre F, Dudhia J, Pujol JP, Bogdanowicz P. 2003. JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression. J Biol Chem 278:2903-2912.
32. Lubberts E, van den Berg WB. 2003. Cytokines in the pathogenesis of rheumatoid arthritis and collagen-induced arthritis. Adv Exp Med Biol 520:194-202.
33. Matsui Y, Chansky HA, Barahmand-Pour F, Zielinska-Kwiatkowska A, Tsumaki N, Myoui A, Yoshikawa H, Yang L, Eyre DR. 2003. COL11A2 collagen gene transcription is differentially regulated by EWS/ERG sarcoma fusion protein and wild-type ERG. J Biol Chem 278:11369-11375.
34. Mengshol JA, Vincenti MP, Brinckerhoff CE. 2001. IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: Requirement for Runx-2 and activation by p38 MAPK and JNK pathways. Nucleic Acids Res 29:4361-4372.
35. Murakami S, Lefebwe V, de Crombrugghe B. 2000. Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-a. J Biol Chem 275:3687-3692.
36. Oettgen P, Alani RM, Barcinski MA, Brown L, Akbarali Y, Boltax J, Kunsch C, Munger K, Libermann TA. 1997. Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family. Mol Cell Biol 17:4419-4433.
37. Oettgen P, Barcinski M, Boltax J, Stolt P, Akbarali Y, Libermann TA. 1999a. Genomic organization of the human ELF3 (ESE-1/ESX) gene, a member of the Ets transcription factor family, and identification of a functional promoter. Genomics 55:358-362.
38. Oettgen P, Kas K, Dube A, Gu X, Grall F, Thamrongsak U, Akbarali Y, Finger E, Boltax J, Endress G, Munger K, Kunsch C, Libermann TA. 1999b. Characterization of ESE-2, a novel ESE-1-related Ets transcription factor that is restricted to glandular epithelium and differentiated keratinocytes. J Biol Chem 274:29439-29452.
39. Okazaki K, Li J, Yu H, Fukui N, Sandell LJ. 2002. CCAAT/enhancer-binding proteins b and d mediate the repression of gene transcription of cartilage-derived retinoic acid-sensitive protein Induced by interleukin-1b. J Biol Chem 270:31526-31533.
40. Okazaki K, Yu H, Davies SR, Imamura T, Sandell LJ. 2006. A promoter element of the CD-RAP gene is required for repression of gene expression in non-cartilage tissues in vitro and in vivo. J Cell Biochem 97:857-868.
41. Osaki M, Tan L, Choy BK, Yoshida Y, Cheah KS, Auron PE, Goldring MB. 2003. The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-g-mediated inhibition in human chondrocytes: Requirement for Stat1 a, Jak1 and Jak2. Biochem J 369:103-115.
42. Poole AR. 2005. Cartilage in health and disease. In: Koopman W, editor. Arthritis and allied conditions: A rextbook of rheumatology. 15 edition. Philadelphia: Lippincott, Williams, and Wilkins. pp. 223-269.
43. Reddy SP, Vuong H, Adiseshaiah P. 2003. Interplay between proximal and distal promoter elements is required for squamous differentiation marker induction in the bronchial epithelium: Role for ESE-1, Sp1, and AP-1 proteins. J Biol Chem 278:21378-21387.
44. Robbins JR, Thomas B, Tan L, Choy B, Arbiser JL, Berenbaum F, Goldring MB. 2000. Immortalized human adult articular chondrocytes maintain cartilage-specific phenotype and responses to interleukin-1b. Arthritis Rheum 43:2189-2201.
45. Rudders S, Gaspar J, Madore R, Voland C, Grall F, Patel A, Pellacani A, Perrella MA, Libermann TA, Oettgen P. 2001. ESE-1 is a novel transcriptional mediator of inflammation that interacts with NF-κB to regulate the inducible nitric-oxide synthase gene. J Biol Chem 276:3302-3309.
46. Ryan MC, Sieraski M, Sandell LJ. 1990. The human type II procollagen gene: Identification of an additional protein-coding domain and location of potential regulatory sequences in the promoter and first intron. Genomics 8:41-48.
47. Sandell LJ, Aigner T. 2001. Articular cartilage and changes in arthritis. An introduction: Cell biology of osteoarthritis. Arthritis Res 3:107-113.
48. Seguin CA, Bernier SM. 2003. TNFa suppresses link protein and type II collagen expression in chondrocytes: Role of MEK1/2 and NF-κ signaling pathways. J Cell Physiol 197:356-369.
49. Silverman ES, Baron RM, Palmer LJ, Le L, Hallock A, Subramaniam V, Riese RJ, McKenna MD, Gu X, Libermann TA, Tugores A, Haley KJ, Shore S, Drazen JM, Weiss ST. 2002. Constitutive and cytokine-induced expression of the ETS transcription factor ESE-3 in the lung. Am J Respir Cell Mol Biol 27:697-704.
50. Sitcheran R, Cogswell PC, Baldwin AS Jr. 2003. NF-κB mediates inhibition of mesenchymal cell differentiation through a posttranscripttonal gene silencing mechanism. Genes Dev 17:2368-2373.
51. Tan L, Peng H, Osaki M, Choy BK, Auron PE, Sandell LJ, Goldring MB. 2003. Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1b. J Biol Chem 278:17688-17700.
52. Tchetina EV, Antoniou J, Tanzer M, Zukor DJ, Poole AR. 2006. Transforming growth factor-b2 suppresses collagen cleavage in cultured human osteoarthritic cartilage, reduces expression of genes associated with chondrocyte hypertrophy and degradation, and increases prostaglandin E(2) production. Am J Pathol 168:131-140.
53. Tetlow LC, Adlam DJ, Woolley DE. 2001. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage. Arthritis Rheum 44:585-594.
54. Thomas B, Berenbaum F, Humbert L, Bian H, Béréziat G, Crofford L, Olivier JL. 2000. Critical role of C/EBPd and C/EBPb factors in the stimulation of cyclooxygenase-2 gene transcription by interleukin-1b in articular chondrocytes. Eur J Biochem 267:1-13.
55. Tower GB, Coon CI, Belguise K, Chalbos D, Brinckerhoff CE. 2003. Fra-1 targets the AP-1 site/2G single nucleotide polymorphism (ETS site) in the MMP-1 promoter. Eur J Biochem 270:4216-4225.
56. Verger A, Duterque-Coquillaud M. 2002. When Ets transcription factors meet their partners. Bioessays 24:362-370.
57. Vincenti MP, Brinckerhoff CE. 2002. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: Integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 4:157-164.
58. Wang H, Fang R, Cho JY, Libermann TA, Oettgen P. 2004. Positive and negative modulation of the transcriptional activity of the ETS factor ESE-1 through interaction with p300, CREB-binding protein, and Ku 70/86. J Biol Chem 279:25241-25250.
59. Wasylyk B, Hagman J, Gutierrez-Hartmann A. 1998. Ets transcription factors: Nuclear effectors of the Ras-Map-kinase signaling pathway. TIBS 23:213-216.
60. Yagi R, McBurney D, Horton WE Jr. 200S. Bcl-2 positively regulates Sox9-dependent chondrocyte gene expression by suppressing the MEK-ERK1/2 signaling pathway. J Biol Chem 280:30517-30525.